REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Go back to REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.88 | 52 Week High | $25.00 | |||
| Open | $7.88 | 52 Week Low | $7.07 | |||
| Day High | $7.88 | P/E | N/A | |||
| Day Low | $7.88 | EPS | $0.00 | |||
| Volume | 8 | |||||
